Factor 7 Medical Bolsters Leadership Team

Factor 7 Medical (F7M) has added five seasoned industry veterans to its executive team in an effort to better help startup companies, growth stage ventures, and established enterprises with their product commercialization goals.

With expertise spanning the entire medtech commercialization spectrum, the expanded leadership team strengthens F7M’s capabilities across five service areas critical for effective and efficient commercialization of medical innovation: product development; regulatory and quality assurance; operations and supply chain management; sales, marketing and reimbursement strategies; and business and capital formation.

“These industry veterans power up our ability to provide specialized, fractional expertise to MedTech companies at every stage of growth,” F7M Founder/Managing Director Dan Sands said. “With this team’s depth of experience, companies can access senior-level guidance in a flexible, cost-effective model—gaining powerful insights that ensure efficient and successful commercialization strategies.”

The new team members each have decades of medtech commercialization experience.

Justin Rowland has been hired as managing partner, Sales and Marketing. A biomedical engineer with an international business degree, Rowland is a business development guru, sales executive, and team leader in the medical device industry.

Before F7M, Rowland’s professional experience includes two medical device consulting firms that provide comprehensive product development services to companies and inventors. He was also an engineer at St. Jude Medical’s (now Abbott’s) CRM division in Sylmar, Calif., and Stryker’s Osteosynthesis division in Kiel, Germany. Rowland has experiences with companies of all sizes as well as various international exposure and experience with surgeon inventors. He knows virtually every aspect of medical device product development.

Rowland earned a bachelor’s degree in biomedical engineering from the Georgia Institute of Technology and a master’s degree in global innovation management from North Carolina State University and Aix-Marseille University in France.

Brogan McGuire—managing partner, Product Development—has more than a decade of experience with medical device product development. McGuire obtained his engineering background from Cal Poly, San Luis Obispo, where he earned a bachelor of science degree in biomedical engineering with a strong focus in orthopedic devices. He has designed, developed, and launched medical devices at both large and small orthopedic companies before entering contract product development. Working at Orchid Design and Kapstone Medical, McGuire quickly established himself as a medtech leader who works aggressively to complete tasks.

Matt Otten is F7M’s new partner, Regulatory and Quality. A medical device industry veteran with more than 35 years of experience in designing, developing, and manufacturing medical devices, Otten holds several medical device patents. He has also designed, launched, and commercialized products for endoscopic, laparoscopic, arthroscopic, cardiovascular, neurovascular, urology, gynecology, general surgery, and many other clinical applications.

Otten began his career in medical devices with Ethicon (Johnson & Johnson) serving in both the product development and operations groups. He was a founding member and vice president for Interplex Medical, a medical device contract manufacturer with facilities in the United States, Asia, Mexico, and Europe.  He was also vice president of Engineering and Manufacturing for SeCQure Surgical and Eccrine Systems.

Otten graduated from Miami University (Ohio) with a degree in mechanical engineering technology. He is a Six Sigma Master Black Belt and has founded or co-founded and led successful medical device companies and service providers.

Kim Frazier—partner, Capital Formation—spent a decade working with technology-based startups in Dayton, Ohio. She helped build a technology commercialization program with the U.S. Air Force research laboratory. Frazier also brought an Ohio Third Frontier-funded Entrepreneurial Service Program to Dayton, building a portfolio of almost 100 companies, one-third of which were medtech startups. To improve Capital Access in the regional ecosystem, she founded a Dayton chapter of Indianapolis-based VisionTech Angels and raised and deployed  a revenue-based investment fund. Frazier later founded EC Angels and grew the angel investor network from 12 to more than 50 investors.  She’s an angel investor herself, with 16 investments in her personal portfolio.

An entrepreneur herself, Frazier founded the restaurant group Speakeasy Enterprises, which includes three restaurants in the Dayton area. She earned a bachelor’s degree from the University of Cincinnati and a master’s degree from Boston University.

Michael Cooper is a seasoned technology executive with more than 20 years of experience in the healthcare sector, particularly in orthopedics. Now the company’s partner, Product Management & Operations, Cooper played a pivotal role at Smith+Nephew Orthopedics for 26 years, where he effectively divided his time between engineering positions in Research and Development and operational and marketing roles focused on comprehensive product management and project management.

Cooper’s expertise encompasses product management, sales training, clinical trials, technical sales, process engineering, polymer processing, team management, global product launches, and biologic research and commercialization. He excels in scaling technology from the research lab to full market readiness, crafting go-to-market strategies, and executing them effectively. Cooper’s profound knowledge of orthopedic devices, positions him as a key contributor to advancements in the field.

Cooper earned both a master’s and bachelor’s degree in engineering science and mechanics, with a specialization in computational and experimental biomechanics from the University of Tennessee, Knoxville. Throughout his career, he has demonstrated the ability to adapt to various industry dynamics and customer requirements, consistently delivering bottom-line results with innovative products and technologies that exceed customer expectations.

In the past two years, Cooper has lent his expertise to the C-suite of a private equity-owned spinoff of Kodak. He has been instrumental in commercializing five innovative products, as well as developing and implementing successful go-to-market processes to reliably launch new products on a global scale.

“F7M was founded on the principle that medtech companies need the right expertise at the right time to achieve meaningful growth,” F7M Board Chairman Bill Phillips stated. “This expansion enables us to serve our clients with even greater depth, ensuring they have the insight, experience, and execution power necessary to bring groundbreaking medical innovations to market.”

Founded in 2021, Factor 7 Medical is redefining how medtech and healthtech companies scale—offering on-demand, high-impact expertise to accelerate product development, navigate regulations, and drive commercial success. Its more than 300 industry experts are experienced in engineering, regulatory, healthcare IT, operations, sales, and marketing. With its flexible, cost-efficient model, the company eliminates barriers and achieves results that accelerates growth and innovation.